Author Piotr Wiland
CASE-BASED REVIEW
Biological treatment in Felty's Syndrome with profound neutropenia
Reumatologia 2023;61(3):213–218
REVIEW PAPER
Pathophysiology of hyperuricemia and its clinical significance – a narrative review
Marta Skoczyńska, Małgorzata Chowaniec, Anna Szymczak, Anna Langner-Hetmańczuk, Beata Maciążek-Chyra, Piotr Wiland
Reumatologia 2020;58(5):312–323
REVIEW PAPER
Classification criteria for secondary Sjögren’s syndrome. Current state of knowledge
Reumatologia 2019;57(5):277–280
ORIGINAL PAPER
Tofacitinib in the treatment of active rheumatoid arthritis – single-centre experience
Marta Madej, Patryk Woytala, Marek Frankowski, Łukasz Lubiński, Renata Sokolik, Agata Sebastian, Beata Maciążek-Chyra, Piotr Wiland
Reumatologia 2019;57(4):192–198
ORIGINAL PAPER
Relapsing polychondritis – analysis of symptoms and criteria
Beata Maciążek-Chyra, Magdalena Szmyrka, Marta Skoczyńska, Renata Sokolik, Joanna Lasocka, Piotr Wiland
Reumatologia 2019;57(1):8–18
GUIDELINES
Tofacitinib in the treatment of patients with rheumatoid arthritis: position statement of experts of the Polish Society for Rheumatology
Eugeniusz J. Kucharz, Marcin Stajszczyk, Anna Kotulska-Kucharz, Bogdan Batko, Marek Brzosko, Sławomir Jeka, Piotr Leszczyński, Maria Majdan, Marzena Olesińska, Włodzimierz Samborski, Piotr Wiland
Reumatologia 2018;56(4):203–211
REVIEW PAPER
Biosimilar switching – current state of knowledge
Piotr Wiland, Bogdan Batko, Marek Brzosko, Eugeniusz J. Kucharz, Włodzimierz Samborski, Jerzy Świerkot, Ewa Więsik-Szewczyk, Julia Feldman
Reumatologia 2018;56(4):234–242
REVIEW PAPER
Interstitial lung disease in systemic sclerosis: challenges in early diagnosis and management
Reumatologia 2018;56(4):249–254
ORIGINAL PAPER
Satisfaction and discontent of Polish patients with biological therapy of rheumatic diseases: results of a multi-center questionnaire study
Anna Kotulska, Eugeniusz J. Kucharz, Piotr Wiland, Marzena Olesińska, Anna Felis-Giemza, Magdalena Kopeć-Mędrek, Aleksandra Zoń-Giebel, Wojciech Romanowski, Lucyna Szymczak-Bartz, Małgorzata Tłustochowicz, Jolanta Lewandowicz, Joanna Kowalska-Majka, Jolanta Bucka, Maria Majdan, Zofia Kiełbik, Mariusz Korkosz, Aneta Bielińska, Piotr Leszczyński, Katarzyna Pawlak-Buś, Mariusz J. Puszczewicz, Dominik Majewski, Katarzyna Smolik, Teresa Migas-Kukla, Małgorzata Sochocka-Bykowska, Maria Szarecka, Bernadeta Luberda, Małgorzata Falenta-Hitnarowicz, Jadwiga Świkszcz-Gniadek, Wanda Lepiarz-Rusek, Grzegorz Rozwadowski, Barbara Chara, Jerzy Zajdel, Zbigniew Zdrojewski, Maria Maciejowska-Roge, Irena Rosmus-Kuczia
Reumatologia 2018;56(3):140–148
ORIGINAL PAPER
Methotrexate treatment for rheumatoid arthritis in Poland: Retrospective analysis of patients in routine clinical practice
Reumatologia 2018;56(1):3–9
ORIGINAL PAPER
Disease activity in axial spondyloarthritis after discontinuation of TNF inhibitors therapy
Agata Sebastian, Patryk Wojtala, Łukasz Lubiński, Małgorzata Mimier, Arkadiusz Chlebicki, Piotr Wiland
Reumatologia 2017;55(4):157–162
ORIGINAL PAPER
Results from Polish Spondyloarthritis Initiative registry (PolSPI) – methodology and data from – the first year of observation
Zofia Guła, Tacjana Barczyńska, Marek Brzosko, Jerzy Gąsowski, Sławomir Jeka, Katarzyna Jodłowska-Cicio, Beata Kwaśny-Krochin, Piotr Leszczyński, Łukasz Lubiński, Katarzyna Łosińska, Katarzyna Pawlak-Buś, Hanna Przepiera-Będzak, Włodzimierz Samborski, Małgorzata Schlabs, Maciej Siedlar, Dorota Sikorska, Jerzy Świerkot, Małgorzata Węgierska, Piotr Wiland, Mariusz Korkosz
Reumatologia 2017;55(2):59–64
CASE REPORT
Palpable mass of the neck in the course of Takayasu arteritis
Reumatologia 2017;55(1):56–60
ORIGINAL PAPER
The initial ultrasonographic examination of hands and feet joints in patients with early rheumatoid arthritis
Reumatologia 2015;53(4):179–185
Cytokine profiles in axial spondyloarthritis
Marta Madej, Beata Nowak, Jerzy Świerkot, Renata Sokolik, Arkadiusz Chlebicki, Lucyna Korman, Patryk Woytala, Łukasz Lubiński, Piotr Wiland
Reumatologia 2015;53(1):9–13
ORIGINAL PAPER
Serum IgG galactosylation in psoriatic arthritis patients undergoing a biological treatment. A preliminary report
Anna Jakubiak-Augustyn, Renata Sokolik, Maria Duk, Jacek Szechiński, Piotr Wiland, Elwira Lisowska, Maciej Sobczyński, Hubert Krotkiewski
Reumatologia 2014;52(6):369–376
CASE REPORT
Granulomatosis with polyangiitis – diagnostic difficulties?
Reumatologia 2014;52(5):344–346
SHORT COMMUNICATION
Recommendations for obstetric management and principles of cooperation between rheumatologists and obstetricians in systemic connective tissue disease patients
Justyna Teliga-Czajkowska, Krzysztof Czajkowski, Maria Majdan, Marzena Olesińska, Joanna Szymkiewicz-Dangel, Lidia Ostanek, Mariola Kosowicz, Piotr Wiland
Reumatologia 2014;52(1):38–48
SHORT COMMUNICATION
Fertility, pregnancy and breastfeeding in systemic lupus erythematosus patients
Maria Majdan, Lidia Ostanek, Marzena Olesińska, Mariola Kosowicz, Justyna Teliga-Czajkowska, Piotr Wiland
Reumatologia 2014;52(1):22–29
SHORT COMMUNICATION
Fertility, pregnancy planning, and pharmacotherapy during the pregnancy, postpartum and breastfeeding period in patients with rheumatoid arthritis and other inflammatory arthropathies
Marzena Olesińska, Lidia Ostanek, Maria Majdan, Mariola Kosowicz, Justyna Teliga-Czajkowska, Piotr Wiland
Reumatologia 2014;52(1):7–21
SHORT COMMUNICATION
planning, and treatment during the pregnancy, postpartum and breastfeeding period in patients with antiphospholipid syndrome
Lidia Ostanek, Maria Majdan, Marzena Olesińska, Mariola Kosowicz, Justyna Teliga-Czajkowska, Piotr Wiland
Reumatologia 2014;52(1):30–37
SHORT COMMUNICATION
Selected principles of proper education of women with rheumatic diseases in respect of pregnancy planning
Mariola Kosowicz, Lidia Ostanek, Maria Majdan, Marzena Olesińska, Justyna Teliga-Czajkowska, Piotr Wiland
Reumatologia 2014;52(1):49–56
ORIGINAL PAPER
Characteristics of Polish patients with systemic lupus erythematosus obtained from SESAME registry. Activity of the disease, degree of impairment, and availability of social care
Piotr Leszczyński, Maria Majdan, Eugeniusz J. Kucharz, Stanisław Sierakowski, Piotr Wiland, Bartłomiej Kisiel, Dominik Dziurda, Tomasz Giemza
Reumatologia 2013;51(5):332–341
Review Paper
B cell depletion with monoclonal antibody as treatment for rheumatoid arthritis
Reumatologia 2006;44(3):162–168
The consensus on rituximab administration in the treatment of patients with rheumatoid arthritis
Jacek Szechliński, Piotr Głuszko, Eugeniusz Józef Kucharz, Włodzimierz Maśliński, Włodzimierz Samborski, Witold Tłustochowicz, Piotr Wiland
Reumatologia 2007;45(3):115–119
The safety and efficacy of adalimumab for the treatment of ankylosing spondylitis (AS) and active psoriatic arthritis (PsA) in patients in a 16-week study
Reumatologia 2007;45(5):248–257
Orginal paper
Efficacy and safety of adalimumab in treatment of patients with rheumatoid arthritis
Reumatologia 2007;45(5):241–247
REVIEW PAPER
Treatment options for patients with rheumatoid arthritis after inadequate response to tumour necrosis factor inhibitors
Reumatologia 2008;46(3):159–167
REVIEW PAPER
Adalimumab – the first fully human monoclonal antibody used in the treatment of rheumatoid arthritis
Jacek Szechiński, Sławomir Jeka, Krzysztof Borysewicz, Anna Filipowicz-Sosnowska, Katarzyna Kolossa, Eugeniusz J. Kucharz, Beata Nowak, Jerzy Świerkot, Piotr Wiland
Reumatologia 2008;46(3):151–158
STANDARDS OF TREATMENT
Position of the Expert Panel of the National Consultant for Rheumatology concerning diagnosis and treatment of rheumatoid arthritis
Witold Tłustochowicz, Marek Brzosko, Anna Filipowicz-Sosnowska, Piotr Głuszko, Eugeniusz J. Kucharz, Włodzimierz Maśliński, Włodzimierz Samborski, Jacek Szechiński, Piotr Wiland
Reumatologia 2008;46(3):111–114
Standard sof treatment
The Expert Panel of the National Consultant for Rheumatology recommendations for the management of ankylosing spondylitis
Piotr Wiland, Anna Filipowicz-Sosnowska, Piotr Głuszko, Eugeniusz J. Kucharz, Włodzimierz Maśliński, Włodzimierz Samborski, Jacek Szechiński, Witold Tłustochowicz, Marek Brzosko
Reumatologia 2008;46(4):191–197
Original paper
The management of patients with rheumatoid arthritis in everyday clinical practice of rheumatologists: the results of a Polish nation-wide questionnaire study
Witold Tłustochowicz, Anna Filipowicz-Sosnowska, Eugeniusz J. Kucharz, Włodzimierz Maśliński, Piotr Wiland
Reumatologia 2008;46(6):330–339
REVIEW PAPER
Tocilizumab – interleukin 6 receptor inhibitor – a new therapeutic option in the treatment of rheumatoid arthritis
Reumatologia 2009;47(2):85–94
SHORT COMMUNICATION
Standards of treatment
of the National Consultant for Rheumatology standpoint for the biologic therapy of juvenile idiopathic arthritis
Lidia Rutkowska-Sak, Ewa Tuszkiewicz-Misztal, Henryka Brózik, Marek Niedziela, Zbigniew Żuber, Witold Tłustochowicz, Piotr Wiland
Reumatologia 2009;47(3):111–115
ORIGINAL PAPER
Anti-HSP70 antibodies in patients with systemic lupus erythematosus
Beata Nowak, Magdalena Szmyrka-Kaczmarek, Anna Durazińska, Krzysztof Borysewicz, Rafał Płaksej, Lucyna Korman, Walentyna Mazurek, Piotr Wiland
Reumatologia 2010;48(1):31–36
ORIGINAL PAPER
Effect of methylenetetrahydrofolate reductase polymorphism on toxicity and efficacy of methotrexate in patients with rheumatoid arthritis
Jerzy Świerkot, Ryszard Ślęzak, Paweł Karpiński, Justyna Pawłowska, Leszek Noga, Jacek Szechiński, Piotr Wiland
Reumatologia 2010;48(2):81–93
ORIGINAL PAPER
Jak3 expression and Stat3 activity in patients with rheumatoid arthritis and spondyloarthropathy
Joanna Krywejko, Dagmara Pokorna-Kałwak, Anna Czarny, Ewa Zaczyńska, Magdalena Szmyrka-Kaczmarek, Piotr Wiland, Andrzej Steciwko
Reumatologia 2010;48(4):237–246
EDITORIAL ARTICLE
Prognostic factors of radiological progression in rheumatoid arthritis
Reumatologia 2010;48(4):213–218
ORIGINAL PAPER
“Long-term assessment of safety and efficacy of biological treatment in juvenile idiopathic arthritis” – the register of Polish patients
Zbigniew Żuber, Lidia Rutkowska-Sak, Jacek Postępski, Witold Tłustochowicz, Piotr Wiland, Ewa Tuszkiewicz-Misztal
Reumatologia 2011;49(1):10–15
REVIEW PAPER
Certolizumab pegol in the treatment of rheumatoid arthritis
Reumatologia 2011;49(4):253–263
REVIEW PAPER
Belimumab – new treatment opportunities in systemic lupus erythematosus
Reumatologia 2012;50(4):349–361
EDITORIAL ARTICLE
Biosymilars in the treatment of rheumatic diseases
Reumatologia 2013;51(6):399–408
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.